Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus APA plus AAP in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415). - Maluf, FC (2020)
Abstract 5505